FCB
NVO

First Citizens Bancorporation’s Novo Nordisk NVO Stock Holding History

First Citizens Bancorporation’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$952K Hold
45,000
– – 0.64% 74
2014
Q3 		$1.07M Buy
+45,000
New +$1.04M 0.77% 53

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

First Citizens Bancorporation's NVO Position: Q4 2014 in Review

First Citizens Bancorporation held its Novo Nordisk (NVO) position steady in Q4 2014 at 45,000 shares worth $952K. The position accounts for 0.64% of the portfolio, ranked #74.

First Citizens Bancorporation first reported a position in NVO in Q3 2014 and has held it in 2 quarters since. The position peaked at $1.07M in Q3 2014. 500 funds tracked by Wall St. Rank hold NVO as of Q4 2014.

  • First Citizens Bancorporation held 45,000 shares of Novo Nordisk worth $952K as of Q4 2014.
  • First Citizens Bancorporation left its Novo Nordisk share count unchanged in Q4 2014.
  • Novo Nordisk made up 0.64% of First Citizens Bancorporation's portfolio in Q4 2014, its #74 holding.
  • First Citizens Bancorporation first reported a position in Novo Nordisk in Q3 2014 and has held it in 2 quarters since.
  • First Citizens Bancorporation's Novo Nordisk position peaked at $1.07M in Q3 2014.
  • 500 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2014.

Based on First Citizens Bancorporation's 13F filing for Q4 2014, filed 21 Jan 2015.